Galectin Therapeutics (GALT) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 158.60% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 49.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.79% |
| Dec 31, 2025 | 52.22% |
| Sep 30, 2025 | 59.12% |
| Jun 30, 2025 | 20.66% |
| Mar 31, 2025 | 36.48% |
| Dec 31, 2024 | -169.52% |
| Sep 30, 2024 | -12.11% |
| Jun 30, 2024 | 15.25% |
| Mar 31, 2024 | -12.16% |
| Dec 31, 2023 | 34.56% |
| Sep 30, 2023 | 8.51% |
| Jun 30, 2023 | -32.38% |
| Mar 31, 2023 | -34.21% |
| Dec 31, 2022 | -4.14% |
| Sep 30, 2022 | -67.01% |
| Jun 30, 2022 | -24.28% |
| Mar 31, 2022 | -26.01% |
| Dec 31, 2021 | -28.39% |
| Sep 30, 2021 | 39.14% |
| Jun 30, 2021 | -129.53% |
| Mar 31, 2021 | -46.01% |
| Dec 31, 2020 | -44.03% |
| Sep 30, 2020 | -456.75% |
| Jun 30, 2020 | -11.76% |
| Mar 31, 2020 | -33.10% |
| Dec 31, 2019 | -87.29% |
| Sep 30, 2019 | 6.47% |
| Jun 30, 2019 | 24.33% |
| Mar 31, 2019 | 6.60% |
| Dec 31, 2018 | 48.59% |
| Sep 30, 2018 | 49.50% |
| Jun 30, 2018 | 38.44% |
| Mar 31, 2018 | 8.98% |
| Dec 31, 2017 | 19.75% |
| Sep 30, 2017 | 9.32% |
| Jun 30, 2017 | -8.50% |
| Mar 31, 2017 | -10.69% |
| Dec 31, 2016 | -5.74% |
| Sep 30, 2016 | 32.26% |
| Jun 30, 2016 | -54.34% |
| Mar 31, 2016 | 19.04% |
| Dec 31, 2015 | -47.80% |
| Sep 30, 2015 | -54.91% |
| Jun 30, 2015 | -23.84% |
| Mar 31, 2015 | -19.12% |
| Dec 31, 2014 | -89.13% |
| Sep 30, 2014 | -121.31% |
| Jun 30, 2014 | -24.84% |
| Mar 31, 2014 | -49.36% |
| Dec 31, 2013 | 6.00% |
| Sep 30, 2013 | 28.67% |
| Jun 30, 2013 | 11.54% |
| Mar 31, 2013 | -63.06% |
| Dec 31, 2012 | -13.55% |
| Sep 30, 2012 | -66.19% |
| Jun 30, 2012 | -44.06% |
| Mar 31, 2012 | -8.71% |
| Dec 31, 2011 | -164.49% |
| Sep 30, 2011 | -51.27% |